Northern Trust’s new Invesco mandate and why it matters for shareholders

Northern Trust (NTRS) is back in focus after Invesco appointed the company to provide administration, custody and depositary services for a new Irish mutual fund range using swap based index replication.

This mandate extends Northern Trust’s existing work across Invesco’s synthetic ETF and digital asset platforms, giving shareholders another data point on how the firm is positioning its asset servicing franchise around complex, index linked products.

The new Invesco mandate lands at a time when Northern Trust’s share price has climbed steadily, with a 30 day share price return of 7.30%, a 90 day share price return of 16.16% and a year to date share price return of 32.60%. The 1 year total shareholder return of 47.64% and 3 year total shareholder return of 156.65% point to strong momentum that this latest client win could help investors reassess against existing fee and cost pressures.

If this kind of mandate driven story has your attention and you are wondering where else growth narratives might be forming, it could be worth scanning 18 top founder-led companies

Bulls argue Northern Trust’s recent mandate win validates its fee pool and growth options, while bears point to a stock that already prices in much of that optimism. Do the current valuation metrics support the bullish side?

Most Popular Narrative: 3% Overvalued

The most followed Northern Trust narrative sets a fair value of $179.35 against a last close of $184.68, so the story currently lags the market price.

The analysts have a consensus price target of $179.35 for Northern Trust based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $200.0, and the most bearish reporting a price target of just $145.0.

Want to see what is baked into that $179.35 fair value? Revenue, earnings and margins all have to line up in a very specific way. The discount rate and profit multiple assumptions add another twist that you can only judge properly by seeing the full narrative.

Result: Fair Value of $179.35 (OVERVALUED)

However, Northern Trust’s story could shift quickly if tech spending runs higher than expected or if fee pressure from passive products increases more than analysts currently assume.

Another View on Northern Trust’s valuation

The analyst narrative suggests Northern Trust is about 3% overvalued against a fair value of $179.35, yet the SWS DCF model points in the opposite direction, with the stock trading about 2.4% below an estimated future cash flow value of $189.23. Which perspective do you consider more compelling?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Northern Trust for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 47 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the mix of optimism and concern around Northern Trust still feels unresolved, use the full dataset to move quickly and shape your own view with 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Northern Trust?

If Northern Trust has sharpened your focus, do not stop here. Broader opportunities across sectors and styles could make a real difference to your long term results.

• Target stability and capital growth by reviewing companies that pass the 47 high quality undervalued stocks.
• Strengthen your income stream by focusing on stocks highlighted in the 8 dividend fortresses.
• Prioritise resilience and peace of mind by filtering for companies in the 82 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.